Want to see JP:3046 full AI Analyst Report?
Top Page
JINS HOLDINGS
(3046)
Select Model
Select Model
Rating:67Neutral
Price Target:
¥6,770.00
▲(9.19% Upside)
Action:Downgraded
Date:07/14/26
The score is primarily supported by strong financial performance (improving margins, solid cash flow generation, and manageable leverage). This is partially offset by weak technical positioning, with the stock trading below key moving averages and showing subdued momentum. Valuation is moderately supportive with a reasonable P/E and a modest dividend yield.
Positive Factors
Improving Profitability
JINS shows durable margin improvement across gross, EBIT and net profit lines, indicating better pricing, cost control and operational efficiency. Sustained margin expansion supports cash generation and reinvestment ability, making earnings quality more resilient over a multi-month horizon.
Negative Factors
Moderate Reliance on Debt
While leverage is declining, an equity ratio that signals measurable debt dependence leaves the company exposed to interest cost variability and refinancing risk. If macro conditions tighten or sales dip, debt servicing could pressure cash flow and limit strategic flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving Profitability
JINS shows durable margin improvement across gross, EBIT and net profit lines, indicating better pricing, cost control and operational efficiency. Sustained margin expansion supports cash generation and reinvestment ability, making earnings quality more resilient over a multi-month horizon.
Read all positive factors
JINS HOLDINGS (3046) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥149.61B
Dividend Yield1.97%
Average Volume (3M)219.61K
Price to Earnings (P/E)18.2
Beta (1Y)0.37
Revenue Growth15.46%
EPS Growth6.44%
CountryJP
Employees3,671
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)340.06
Shares Outstanding23,980,000
10 Day Avg. Volume250,300
30 Day Avg. Volume219,606
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)5.90
Price to Sales (P/S)1.93
P/FCF Ratio21.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)375.21
Revenue Forecast (FY)¥111.13B
JINS HOLDINGS Business Overview & Revenue Model
Company Description
JINS HOLDINGS Inc. is a Japanese corporation, operating through its subsidiaries, primarily involved in the design, manufacturing, wholesale, and retail of optical products and various fashion accessories. Its product portfolio includes a range of...
How the Company Makes Money
JINS HOLDINGS makes money mainly by selling eyewear products to end consumers under the JINS brand. Its core revenue stream is retail sales of prescription eyeglasses, where it captures value through an integrated model that typically includes pro...
JINS HOLDINGS Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
82
Very Positive
| Breakdown | TTM | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.89B | 97.22B | 83.00B | 73.26B | 66.90B | 63.90B |
| Gross Profit | 80.61B | 72.89B | 61.55B | 53.34B | 49.18B | 47.72B |
| EBITDA | 15.10B | 15.04B | 10.76B | 7.76B | 6.27B | 7.75B |
| Net Income | 7.94B | 8.33B | 4.67B | 1.76B | 750.00M | 3.29B |
Balance Sheet | ||||||
| Total Assets | 60.02B | 58.41B | 54.53B | 45.24B | 54.95B | 53.01B |
| Cash, Cash Equivalents and Short-Term Investments | 8.82B | 11.98B | 18.67B | 12.20B | 21.43B | 23.21B |
| Total Debt | 5.00B | 8.28B | 12.37B | 12.99B | 23.57B | 24.25B |
| Total Liabilities | 26.13B | 26.66B | 28.94B | 23.46B | 34.54B | 32.78B |
| Stockholders Equity | 33.88B | 31.74B | 25.59B | 21.78B | 20.41B | 20.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.53B | 9.10B | 3.14B | 1.73B | 3.47B |
| Operating Cash Flow | 0.00 | 10.53B | 10.99B | 6.05B | 4.39B | 5.06B |
| Investing Cash Flow | 0.00 | -7.86B | -2.38B | -3.85B | -3.85B | -3.17B |
| Financing Cash Flow | 0.00 | -9.43B | -2.33B | -11.50B | -2.77B | -3.76B |
JINS HOLDINGS Technical Analysis
Negative
6200.00
Price Trends
7860.40
Negative
6746.53
Negative
6603.34
Negative
Market Momentum
-348.27
Positive
30.51
Neutral
6.97
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3046, the sentiment is Negative. The current price of 6200 is below the 20-day moving average (MA) of 7755.00, below the 50-day MA of 7860.40, and below the 200-day MA of 6603.34, indicating a bearish trend. The MACD of -348.27 indicates Positive momentum. The RSI at 30.51 is Neutral, neither overbought nor oversold. The STOCH value of 6.97 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3046.
JINS HOLDINGS Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥8.37T | 33.58 | 25.14% | 1.01% | 9.44% | 28.08% | |
77 Outperform | ¥7.05B | 14.13 | ― | 2.95% | 7.03% | 5.38% | |
74 Outperform | ¥58.47B | 14.34 | ― | 3.22% | 13.57% | 0.34% | |
67 Neutral | ¥149.61B | 18.20 | 27.95% | 1.97% | 15.46% | 6.44% | |
54 Neutral | ¥131.25B | 21.84 | 7.81% | 1.78% | 3.39% | 6.84% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥15.71B | 13.84 | ― | 2.65% | 2.14% | 3.96% |
* Healthcare Sector Average
JP:3046
JINS HOLDINGS
6,410.00
-1,440.55
-18.35%
JP:7741
HOYA
25,050.00
6,922.47
38.19%
JP:7780
Menicon Co
1,725.00
590.12
52.00%
JP:5889
Japan Eyewear Holdings Co.,Ltd.
2,416.00
357.52
17.37%
JP:7743
Seed Co., Ltd.
519.00
60.28
13.14%
JP:9340
ASO INTERNATIONAL INC.
718.00
143.05
24.88%
JINS HOLDINGS Corporate Events
JINS HOLDINGS Delivers Strong Sales Growth and Raises Dividend Outlook
Jul 10, 2026
JINS HOLDINGS reported consolidated net sales of ¥80.73 billion for the nine months ended May 31, 2026, up 15.6% year on year, with operating profit edging up 1.2% to ¥8.99 billion. Profit attributable to owners of parent slipped 0.7% to...
JINS HOLDINGS Grows June Sales and Store Network Despite Softer Traffic
Jul 3, 2026
JINS HOLDINGS reported that in June 2026, sales across all its eyewear stores in Japan rose 7.6% year on year, while existing store sales were effectively flat, edging down 0.1%. Customer traffic was dampened by adverse weather and one fewer holid...
JINS HOLDINGS Posts Double-Digit May Sales Surge as Store Network Expands in Japan
Jun 5, 2026
JINS HOLDINGS reported strong May 2026 performance in its Japan eyewear business, with all-store sales up 26.4% year-on-year and existing store sales rising 17.2%. The retailer ended the month with 581 stores, reflecting continued network expansio...
JINS HOLDINGS Posts Strong April Sales and Opens Flagship Shinjuku Store
May 8, 2026
JINS HOLDINGS reported strong April 2026 performance at its Japanese eyewear stores, with all-store sales up 18.2% year on year and existing-store sales rising 10.5%. The gains were driven by higher average spend per customer, effective promotiona...
JINS to Take Direct Control of Philippine Eyewear Operations with Suyen Deal
Apr 24, 2026
JINS HOLDINGS will convert its JINS-branded franchise operations in the Philippines into a directly managed business by having its wholly owned subsidiary, JINS Philippines Inc., acquire Suyen Corporation’s local eyewear retail operations. T...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.